Participants 77 132 4
hyperphosphatemic patients with end-stage renal disease
Participants 193 241 5
patients receiving long-term dialysis treatment.
Participants 377 422 4
patients with end-stage renal disease (ESRD).
Participants 582 611 3
in Chinese patients with ESRD
Participants 749 786 3
male and female hemodialysis patients
